Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

David Lyreskog


Neuroethics Researcher

About me

I am a neuroethics researcher with the Neuroscience, Ethics & Society (NEUROSEC) team at the Department of Psychiatry, and with the Wellcome Centre for Ethics & Humanities (WEH).

Broadly interested in impactful neuroethics research, I specialise in the analysis of ethical issues in the intersection of Psychiatry (mental health, neuroscience), new and emerging technologies, and decision-making.


I am currently leading the WEH research line Rethinking Collective Minds, where we investigate the conceptual and ethical impacts of emerging technologies for collective thinking, sensing, and decision-making.

Since the summer of 2023, I am a Co-Investigator on AI-PROGNOSIS – a Horizon Europe-funded project developing Artificial intelligence-based solutions for Parkinson’s Disease risk assessment, prognosis, and management.

Between 2019 and 2021 I worked on the Wellcome-funded project BeGOOD Early Intervention Ethics in Child and Adolescent Mental Health, developing novel tools for bioethics research and engagement with young people. In this project, we built a digital game – 'Tracing Tomorrow' – to study the values and preferences of young people in the context of digital phenotyping for mental health in schools.


My background being in the field of analytic philosophy, I have a MA in Philosophy from Umeå University, Sweden. My Magistrate (1 year MA) thesis explored the landscape of moral enhancement as a means for criminal rehabilitation (2013), and my Masters (2 year MA) thesis discussed ethical issues in decision-making processes leading up to deep brain stimulation (DBS) in paediatric populations (2014).

My PhD thesis, The Ethics of Mind Maintenance (2020), analysed ethical trade-offs in the context of emerging technologies aimed at preventing and treating age-related neural decline and disease. The project sought to facilitate our understanding of the value trade-offs involved in utilising technologies for neurodegenerative diseases, the aim being to provide a guiding and ethically sound decision-making structure for patients and other users of the technologies.